A non-invasive, point-of-care device, which identifies the sickle-cell Disease SCD. It is self contained, portable and battery operated making it suitable for mass screening of rural population without affecting their routine work.
Benefits
The epidemiological report states that millions of people are affected by SCD worldwide mainly in sub-Saharan Africa, central India, and eastern Brazil. It is of growing importance in the global health context specially affecting the rural and tribal community in a developing country like India.
Biotechnology Industry Research Assistance Council, New Delhi
Quick Information
Thrust Areas
Medical Sciences
Focus Area
Healthcare, Digital Health
Status
Early stage Validation
Output
Status
Early stage Validation
TRL: Technology Readiness Level
TRL-5
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Chrogene Aarogyam Biotech Private Limited, Hyderabad.
Accessibility Controls